Trials / Recruiting
RecruitingNCT06895603
The HIgh-fidelity Hydraulic couPling Upper-arm Cuff Assessment of Limits, Safety, and Effectiveness (HIPULSE) Trial (Cardiac Output Study)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 75 (estimated)
- Sponsor
- Philips Clinical & Medical Affairs Global · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare cardiac output (CO), fluid responsiveness, and related measurements between the Philips AMC and PAC (Swan-Ganz) in ICU or surgical patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Philips Advanced Monitoring Cuff (AMC) | The Philips AMC is a Class II (USA) and Class IIb (EU) medical device that is a non-invasive, semirigid disposable upper arm cuff with an integrated pneumatic actuator enabling hydraulic coupling of tissue pressure waveforms from the upper arm tissue. |
Timeline
- Start date
- 2025-10-28
- Primary completion
- 2026-02-01
- Completion
- 2026-06-01
- First posted
- 2025-03-26
- Last updated
- 2026-02-27
Locations
2 sites across 2 countries: United States, Germany
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06895603. Inclusion in this directory is not an endorsement.